| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00001703-199802000-00007 |
| P953 | full work available at URL | https://journals.lww.com/00001703-199802000-00007 |
| P698 | PubMed publication ID | 9484627 |
| P50 | author | Tom Bourne | Q45956465 |
| P2093 | author name string | S. Campbell | |
| W. P. Collins | |||
| P2860 | cites work | Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials | Q34027970 |
| Parity, contraception, infertility, and the risk of epithelial ovarian cancer | Q34324523 | ||
| Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. | Q34732921 | ||
| Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. | Q35187046 | ||
| Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography | Q35187056 | ||
| Transabdominal ultrasound screening for early ovarian cancer | Q35719293 | ||
| Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study | Q36601557 | ||
| Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction | Q40732671 | ||
| Controversies in assessment of ovarian tumors with transvaginal color Doppler ultrasound | Q40991623 | ||
| Early detection and screening for ovarian cancer | Q41070295 | ||
| Role of BRCA1 mutation screening in the management of familial ovarian cancer | Q41129150 | ||
| Genetic epidemiology of ovarian cancer: segregation analysis | Q41141907 | ||
| The genetics of ovarian cancer: an assessment of current screening protocols and recommendations for counseling families at risk | Q41230044 | ||
| Hereditary ovarian cancer: molecular genetics and clinical implications | Q41351821 | ||
| The status of ultrasound and color Doppler imaging for the early detection of ovarian carcinoma | Q41488837 | ||
| Transvaginal sonography as a screening method for the detection of early ovarian cancer | Q41505039 | ||
| A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers | Q41578392 | ||
| Cancer mortality in relatives of women with ovarian cancer: the OPCS Study. Office of Population Censuses and Surveys | Q47648595 | ||
| Sonographic prediction of malignancy in adnexal masses using multivariate logistic regression analysis. | Q52260532 | ||
| Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers | Q52323667 | ||
| Early detection of familial ovarian cancer | Q52891983 | ||
| Elevation of multiple serum markers in patients with stage I ovarian cancer | Q53387590 | ||
| Intratumoral peak systolic velocity as a new possible predictor for detection of adnexal malignancy | Q54173299 | ||
| Genetic epidemiology of epithelial ovarian cancer | Q57250659 | ||
| Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group | Q67979093 | ||
| Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound | Q71079562 | ||
| Current role of ultrasound in ovarian cancer screening | Q71089603 | ||
| Feasibility study of a randomised trial of ovarian cancer screening among the general population | Q71494623 | ||
| CA 125 as a screening test for ovarian cancer | Q71661769 | ||
| Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses | Q71738742 | ||
| Software for illustrative presentation of basic clinical characteristics of laboratory tests--GraphROC for Windows | Q71767755 | ||
| Screening for ovarian cancer | Q71770034 | ||
| A comparison of intratumoural indices of blood flow velocity and impedance for the diagnosis of ovarian cancer | Q71788377 | ||
| Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer | Q71974018 | ||
| Screening for ovarian cancer | Q72029780 | ||
| The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer | Q72361866 | ||
| The efficacy of a sonographic morphology index in identifying ovarian cancer: a multi-institutional investigation | Q72801734 | ||
| Serum CA-125 screening for ovarian cancer in patients with dermatomyositis | Q73355743 | ||
| Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes | Q73401629 | ||
| Transvaginal ultrasound-guided ovarian endoscopy: a novel approach to the assessment of ovarian tumors | Q73503976 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 33-39 | |
| P577 | publication date | 1998-02-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Current Opinion in Obstetrics and Gynecology | Q15765701 |
| P1476 | title | Screening strategies for ovarian cancer | |
| P478 | volume | 10 |
| Q73614105 | Benign ovarian cysts and ovarian cancer: a cohort study with implications for screening |
| Q102152334 | Clinical usefulness of high levels of C-reactive protein for diagnosing epithelial ovarian cancer |
| Q35309119 | Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies. |
| Q34483853 | Early Detection of Ovarian Cancer: Promise and Reality |
| Q92643944 | Improved early detection of ovarian cancer using longitudinal multimarker models |
| Q55622028 | MONITORING OF CHEMOTHERAPY SUCCESSFULNESS OF PLATINA/TAXOL CHEMOTHERAPY PROTOCOL BY USING DETERMINATION OF SERUM UROKINASE PLASMINOGEN ACTIVATOR (UPA) AND SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IN PATIENTS WITH OVARIAN CARCINOMA FI |
Search more.